- Home
- ESS vs HOLX Comparison
ESS vs HOLX Comparison
Compare ESS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESS | HOLX |
|---|---|---|
| Founded | 1971 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Electronics |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 16.9B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ESS | HOLX |
|---|---|---|
| Price | $249.64 | $76.02 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 16 | 13 |
| Target Price | ★ $281.83 | $77.89 |
| AVG Volume (30 Days) | 409.9K | ★ 8.6M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 10.40 | 0.79 |
| Revenue | $1,887,345,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $1.89 | $4.74 |
| Revenue Next Year | $3.30 | $5.03 |
| P/E Ratio | ★ $24.01 | $96.23 |
| Revenue Growth | ★ 6.36 | 1.74 |
| 52 Week Low | $238.46 | $51.90 |
| 52 Week High | $294.09 | $76.07 |
Technical Indicators
Market Signals| Indicator | ESS | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 69.09 |
| Support Level | $248.17 | $75.10 |
| Resistance Level | $263.53 | N/A |
| Average True Range (ATR) | 4.45 | 0.19 |
| MACD | 1.20 | 0.03 |
| Stochastic Oscillator | 75.26 | 95.19 |
Price Performance
Historical ComparisonAbout ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 259 apartment communities with over 63,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.